Insights

Gathering insights about EnGen…

Similar companies to EnGen

EnGen Tech Stack

EnGen uses 8 technology products and services including jQuery CDN, NoSQL, Zendesk, and more. Explore EnGen's tech stack below.

jQuery CDN
Content Delivery Network
NoSQL
Database
Zendesk
Documentation Tools
Google Fonts API
Font Scripts
Choices
Javascript Libraries
HSTS
Security
Google Analytics
Web Analytics
Nginx
Web Servers

Media & News

Market Today: WBD Bid, Alphabet Energy Deal, Uber Robotaxis
Stock News Paramount ups WBD bid financing: Paramount Skydance (PSKY) said Larry Ellison will personally guarantee $40.4B of equity for its $30/share all-cash h
Dec 22, 2025 | www.gurufocus.com
enGene Reports Full Year 2025 Financial Results and Provides Business Update
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the full year ended October 31, 2025, and provided a business update. “We are closing 2025 in a position of strength: enrollment in LEGEND's pivotal cohort is complete and the recent data update from the LEGEND pivotal cohort supports an emerging, competitive profile for the use of detalimogene as the.
Dec 22, 2025 | www.businesswire.com
enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that the U.S. Food and Drug Administration (FDA) has selected detalimogene voraplasmid (also known as detalimogene and previously EG-70) to participate in the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) Program. Detalimogene is a novel, investigational, non-viral gene therapy for patie.
Dec 02, 2025 | www.businesswire.com
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral genetic medicines company, today announced that Alex Nichols, Ph.D., Chief Strategy and Operations Officer, will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025, at 12:10 p.m. ET. A webcast of the presentation can be accessed on the "Events and Presentations” page under the “Investors” section of the enGene website at www.engene.com and wil.
Nov 25, 2025 | www.businesswire.com
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced the pricing of its previously announced underwritten public offering of 12,558,823 common shares at a public offering price of $8.50 per share and pre-funded warrants to purchase 2,735,295 shares of its common shares at an offering price of $8.4999 per pre-funded warrant, in each case, before underwriting discounts and commiss.
Nov 13, 2025 | www.businesswire.com
enGene Announces Proposed Public Offering of Common Shares
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that it has commenced an underwritten public offering of its common shares. All common shares to be sold in the offering will be offered by enGene. In addition, enGene intends to grant the underwriters a 30-day option to purchase up to a number of additional common shares equal to 15% of the total number of common shares sold.
Nov 12, 2025 | www.businesswire.com
enGene Holdings: Still A Buy After A Massive Surge
enGene Holdings remains a Buy, driven by promising LEGEND trial data for detalimogene voraplasmid in non-muscle invasive bladder cancer. ENGN's phase 2 LEGEND trial showed a 63% complete response rate, comparable to ImmunityBio's Anktiva, positioning ENGN as a strong NMIBC contender. ENGN has a robust cash runway into 2027, supporting continued operations and potential approval without immediate fundraising concerns.
Nov 12, 2025 | seekingalpha.com

EnGen's Email Address Formats

EnGen uses at least 1 format(s):

EnGen Email Formats	Example	Percentage
First@getengen.com	John@getengen.com	50%
First@getengen.com	John@getengen.com	50%

Frequently Asked Questions

What is EnGen's stock symbol?

EnGen is a publicly traded company; the company's stock symbol is ENGN.

What is EnGen's official website and social media links?

EnGen's official website is getengen.com and has social profiles on LinkedIn.

What is EnGen's NAICS code?

EnGen's NAICS code is 6114 - Business Schools and Computer and Management Training.

How many employees does EnGen have currently?

As of December 2025, EnGen has approximately 75 employees across 2 continents, including North AmericaAfrica. Key team members include Ceo And Board Member: G. L.Cto: M. W.Founder & Chief Education Officer: K. B.. Explore EnGen's employee directory with LeadIQ.

What industry does EnGen belong to?

EnGen operates in the E-Learning Providers industry.

What technology does EnGen use?

EnGen's tech stack includes jQuery CDNNoSQLZendeskGoogle Fonts APIChoicesHSTSGoogle AnalyticsNginx.

What is EnGen's email format?

EnGen's email format typically follows the pattern of First@getengen.com. Find more EnGen email formats with LeadIQ.

EnGen

Q: What is EnGen's official website and social media links?

EnGen's official website is getengen.com. EnGen has social profiles on LinkedIn.

Q: How many employees does EnGen have currently?

EnGen has approximately 75 employees.

Q: What technology does EnGen use?

EnGen's tech stack includes Datadog, HubSpot, Google Tag Manager, Vue.js, YouTube.

E-Learning ProvidersMaryland, United States51-200 Employees

EnGen delivers career-aligned, on-demand English instruction at the scale needed to serve the needs of the U.S. workforce – including English learners, who now represent 1 in 10 working-age adults. A Certified B Corporation, EnGen partners with employers and organizations that are focused on advancing career mobility, retention, engagement, and talent development. The platform is built with patented, AI-powered technology that has served more than 4 million language learners worldwide.